Experimental Ebola Drug Raises Questions
ONE: Drugs for Ebola — but will they work?
Andrew Marshall, senior director for global digital content at ONE, discusses the practical and moral issues surrounding the use of the unlicensed Ebola drug ZMapp (8/13).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.